Iridian Asset Management’s Elevance Health ELV Stock Holding History

Iridian Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-9,900	Closed	-$4.86M	–	54
2022 Q1	$4.86M	Buy	9,900 +400	+4%	+$183K	0.34%	42
2021 Q4	$4.4M	Hold	9,500	–	–	0.27%	48
2021 Q3	$3.54M	Hold	9,500	–	–	0.11%	53
2021 Q2	$3.63M	Hold	9,500	–	–	0.06%	57
2021 Q1	$3.41M	Hold	9,500	–	–	0.06%	64
2020 Q4	$3.05M	Buy	9,500 +4,500	+90%	+$1.38M	0.06%	59
2020 Q3	$1.34M	Buy	+5,000	New	+$1.35M	0.03%	59

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Iridian Asset Management's ELV Position: Q2 2026 in Review

Iridian Asset Management reduced its Elevance Health (ELV) stake by 31% in Q2 2026, selling an estimated $2.46M and leaving 14,989 shares worth $5.8M. The position accounts for 1.99% of the portfolio, ranked #16.

Iridian Asset Management first reported a position in ELV in Q2 2018 and has held it in 33 quarters since. The position peaked at $430M in Q3 2018. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

Iridian Asset Management held 14,989 shares of Elevance Health worth $5.8M as of Q2 2026.
Iridian Asset Management sold 6,636 Elevance Health shares in Q2 2026, an estimated $2.46M.
Elevance Health made up 1.99% of Iridian Asset Management's portfolio in Q2 2026, its #16 holding.
Iridian Asset Management first reported a position in Elevance Health in Q2 2018 and has held it in 33 quarters since.
Iridian Asset Management's Elevance Health position peaked at $430M in Q3 2018.
1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Iridian Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.